• Company
• “Will become a CRO specializing in cell·gene therapy”
• by Lee, Tak-Sun May 9, 2022 06:04am

• Company
• Companies reattempt to avoid Dukarb's patent in 2nd trial
• by Kim, Jin-Gu May 9, 2022 06:03am

• Company
• GLP-1 diabetes drugs are being released one after another
• by May 9, 2022 06:03am

• Company
• Sales of Losartan are plummeting due to the impurity crisis
• by Chon, Seung-Hyun May 9, 2022 06:03am

• Hunterase makes new record in overseas exports
• by Chon, Seung-Hyun May 6, 2022 05:46am

• Company
• Breast cancer supplement Nerlynx is available in hospitals
• by Eo, Yun-Ho May 6, 2022 05:46am

• Opinion
• [Reporter’s View] Now is the time for drug reclassification
• by Lee, Tak-Sun May 6, 2022 05:46am

• Policy
• Only 40% of asthma pts undergo Pulmonary function testing
• by Lee, Tak-Sun May 6, 2022 05:46am

• Company
• Hospitals Busy Introducing Kymriah
• by Moon, sung-ho May 6, 2022 05:45am

• Company
• Risk of Impurities in Treatment of Schizophrenia
• by Chon, Seung-Hyun May 4, 2022 06:04am